Skip to main content

Sutter Martin P's Form 4 filing

Abiomed IncABMD · filed Feb 17, 2022

Accession no.
0001179110-22-001400
Filed
Feb 17, 2022
Trade date
Feb 17, 2022
Filing delay
Same day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 11 non-derivative transactions. Open-market sales total $1.26M. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Sutter Martin PCIK 0001017832Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−260$307.64F1−$79,986.4134,130Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−424$308.80F2−$130,931.2133,706Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−328$309.74F3−$101,594.72133,378Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−254$310.65F4−$78,905.1133,124Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−346$311.69F5−$107,844.74132,778Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−193$312.64F6−$60,339.52132,585Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−48$313.82F7−$15,063.36132,537Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−798$316.02F8−$252,183.96131,739Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−147$316.92F9−$46,587.24131,592Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−1,153$320.61F10−$369,663.33130,439Direct
Feb 17, 2022Common Stock, $0.01 par valueSSaleDisposed−49$321.61F11−$15,758.89130,390Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

This price represents the sale price of the transactions on the reported date at $307.63. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F2

This price represents the sale price of the transactions on the reported date at $308.79. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F3

This price represents the sale price of the transactions on the reported date at $309.73. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F4

This price represents the sale price of the transactions on the reported date at $310.64. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F5

This price represents the sale price of the transactions on the reported date at $311.69. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F6

This price represents the sale price of the transactions on the reported date at $312.63. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F7

This price represents the sale price of the transactions on the reported date at $313.82. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F8

This price represents the sale price of the transactions on the reported date at $316.01. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F9

This price represents the sale price of the transactions on the reported date at $316.91. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F10

This price represents the sale price of the transactions on the reported date at $320.60. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

F11

This price represents the sale price of the transactions on the reported date at $321.61. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)